Pfizer/BioNTech has submitted data to the EU's medicines regulator for the approval of their coronavirus vaccine for children aged five to 11, following a similar step in the United States.
The vaccine makers announced last month that trial results had shown their jab was safe and created a "robust" immune response in that age group.
The European Medicines Agency said it will review data related to the vaccine, known as Comirnaty, including results from an ongoing clinical study.
Pfizer/BioNTech said the study involved 2,268 children ages five to 11 and data has been submitted to the EMA with a view to securing "Conditional Marketing Authorisation in the European Union". Latest coronavirus stories Professor Brian MacCraith, Chair of